For new medicines in India, trial must on Indians

In a move to ensure efficacy of medicines sold in India, the drug regulator has made it mandatory for companies to include Indian patients in global clinical trials if they want to market in India a new drug developed outside the country.

from Times of India http://ift.tt/2wLNXeX